TGFB1 and neoplasm: Among the pro-tumor mechanisms promoted by TAMs, TGF-β signaling represents a powerful activator of epithelial-to-mesenchymal transition (EMT), a process that plays a crucial role in CRC metastasis and in the resistance to chemotherapy and immunotherapy drugs [10,11,12,13].